Please assess the completion status of the following clinical trial:

Trial Title: A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stable without clinically significant disease~Exclusion Criteria:~* Use of NSAID within 2 weeks~* Type 1 or 2 DM~* GI disorder

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): PN400 + ASA
- 2 (Type: PLACEBO_COMPARATOR): Placebo + ASA

Based on this trial design, predict the completion outcome and termination type (if applicable).